Skip to content

Author

Malik Alawi

We have 1 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer

A previously undescribed expression signature with potential predictive value for bevacizumab benefit is identified, and transcriptional heterogeneity of ovarian cancer that extends beyond current molecular classifications is revealed.

O. Zolotareva, K. Legler, O. Tsoy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.